MedPath

The Finnish Faecal Microbiota Transplantation Study (FINFMT)

Recruiting
Conditions
Faecal Microbiota Transplantation
Registration Number
NCT03732131
Lead Sponsor
Joint Authority for Päijät-Häme Social and Health Care
Brief Summary

The objective of the study is to follow up the long term effects of faecal microbiota tranplantation (FMT). All the over 18 years old patients receiving FMT and not included in other trials meet inclusion criteria to this study. Patients will be asked for a written consent. The outcome and possible side effects of the FMT will be followed by blood and feces samples for one year and with questionaires up to ten years after the FMT.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
200
Inclusion Criteria
  • > 18 years age
  • receiving FMT for rCDI or any other madical condition
  • written consent
  • Not included in other FMT trials
Exclusion Criteria
  • Unable to provide written consent
  • < 18 years age
  • Included in other FMT-trial

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The long term effects of FMT -questionnaire10 years

The questionnaire has 52 questions. Weight and height are asked and appearance of certain symptoms. The answers are mostly yes or no. The questionnaire is not validated and it is descriptive and the answers are not scored.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Joint Authority for Päijät-Häme Social and Health Care

🇫🇮

Lahti, Finland

Joint Authority for Päijät-Häme Social and Health Care
🇫🇮Lahti, Finland
Perttu Lahtinen, MD
Contact
+358-3-81911
perttu.lahtinen@phhyky.fi

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.